Haemonetics Corp. (HAE)
103.64
+1.69
(+1.66%)
USD |
NYSE |
Sep 02, 10:41
Haemonetics Cash from Operations (Annual) : 293.22M for March 31, 2026
Cash from Operations (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| March 31, 2026 | 293.22M |
| March 31, 2025 | 181.72M |
| March 31, 2024 | 181.75M |
| March 31, 2023 | 271.94M |
| March 31, 2022 | 172.26M |
| March 31, 2021 | 108.80M |
| March 31, 2020 | 158.22M |
| March 31, 2019 | 159.28M |
| March 31, 2018 | 220.35M |
| March 31, 2017 | 159.74M |
| March 31, 2016 | 121.86M |
| March 31, 2015 | 127.18M |
| March 31, 2014 | 139.52M |
| March 31, 2013 | 85.07M |
| March 31, 2012 | 115.32M |
| March 31, 2011 | 123.46M |
| March 31, 2010 | 130.67M |
| March 31, 2009 | 116.36M |
| Date | Value |
|---|---|
| March 31, 2008 | 77.67M |
| March 31, 2007 | 83.56M |
| March 31, 2006 | 85.62M |
| March 31, 2005 | 71.21M |
| March 31, 2004 | 76.77M |
| March 31, 2003 | 43.67M |
| March 31, 2002 | 32.24M |
| March 31, 2001 | 61.01M |
| March 31, 2000 | 53.46M |
| March 31, 1999 | 33.71M |
| March 31, 1998 | 20.40M |
| March 31, 1997 | 26.74M |
| March 31, 1996 | 54.81M |
| March 31, 1995 | 15.63M |
| March 31, 1994 | 27.01M |
| March 31, 1993 | 35.92M |
| March 31, 1992 | 18.85M |
| March 31, 1991 | 26.08M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Globus Medical, Inc. | 753.45M |
| Abbott Laboratories | 9.566B |
| AngioDynamics, Inc. | 3.089M |
| Alphatec Holdings, Inc. | 45.23M |
| AtriCure, Inc. | 57.33M |